Salvage therapy with decitabine in combination with granulocyte colony‐stimulating factor, low‐dose cytarabine, and aclarubicin in patients with refractory or relapsed early T‐cell precursor acute lymphoblastic leukemia
Tongyan Meng, Yao Yao, Yang Xu, Shengli Xue, Yue Han, Xiaowen Tang, Huiying Qiu, Aining Sun, Depei Wu, Yanming Zhang, Ying Wang
Abstract
The peer review history for this article is available at https://publons.com/publon/10.1002/hon.2783.
Topics & Concepts
AclarubicinDecitabineMedicineCytarabineRefractory (planetary science)Granulocyte colony-stimulating factorLymphoblastic LeukemiaSalvage therapyInternal medicineOncologyLeukemiaCancer researchChemotherapyBiologyBiochemistryDNA methylationGene expressionGeneAstrobiologyAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and TreatmentChronic Myeloid Leukemia Treatments